Pulmonx第四季度每股收益为$(0.33),优于预期的$(0.45),销售额为2377万美元,优于预期的2229万美元

财报速递
20 Feb
Pulmonx (NASDAQ:LUNG)报告季度每股亏损$(0.33),比分析师一致预期的$(0.45)高出26.67%。这比去年同期每股亏损$(0.36)提高了8.33%。公司报告季度销售额为2377万美元,高于分析师一致预期的2229万美元,高出6.61%。这比去年同期的1928万美元增长了23.28%。

以上内容来自Benzinga Earnings专栏,原文如下:

Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.45) by 26.67 percent. This is a 8.33 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $23.77 million which beat the analyst consensus estimate of $22.29 million by 6.61 percent. This is a 23.28 percent increase over sales of $19.28 million the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10